Become a New Member!

Post a Career Opportunity

List a Professional Resource

Membership Renewal

Having Trouble?

Trouble with Membership Renewal?

Upcoming Events

 "Cancer Moonshot 2020"

Speaker: Carla Balch, President, NantCRO/NantCare/NantKwest

Thursday, May 19, 2016

NC Biotech Center, RTP


 US RAC Workshop
Registration now OPEN!

Click here to Register




PDF Email

April 14:                                                       NCRAF is on LinkedIn!

North Carolina Regulatory Affairs Forum

NCRAF is an association of regulatory affairs professionals centered in the Raleigh-Durham-Chapel Hill "Triangle" of North Carolina USA. NCRAF is dedicated to providing education and support for the continuing professional development of individuals who have an interest in regulatory affairs activities as they apply to research, development, or manufacture of drugs, biologics, or medical devices.

Upcoming  NCRAF Events:


NCRAF Spring Symposium: A Regulatory Overview of Cancer MoonShot2020

Thursday, May 19, 2016
N.C. Biotech Center

Speaker:  Carla Balch, President of NantCare and NantCRO

Early this year, leaders from large pharma including Celgene and Amgen, biotech including NantWorks, NantKwest, Etubics, Altor Bioscience, and Precision Biologics, major academic cancer centers and community oncologists announced the launch of ‎The National Immunotherapy Coalition (NIC), a historic alliance--with a singular focus: accelerating the potential of combination immunotherapies as the next generation standard of care in patients with cancer.

This unprecedented collaboration of multinational pharmaceutical, biotechnology companies, academic centers and community oncologists will make possible access to over 60 novel and approved agents under exploration in the war against cancer and will enable rapid testing of novel immunotherapy combination protocols, forming the basis of ‎ The Cancer MoonShot 2020 . The NIC will design, initiate and complete randomized clinical trials in cancer patients with cancer at all stages of disease in up to 20 tumor types in as many as 20,000 patients by the year 2020 through the QUILT Program.




Tuesday evenings, June 7, 2016 through early October, 2016


 The eCTD Group - Wednesday May 11, 2016

at Impact Pharma, 70 TW Alexander Drive, Building 4401, Suite 100, RTP

Jeff Golden will be discussing the "CMC Book of Knowledge"
Click here for more information